U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 344

1.
Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells
Eri Takiguchi, Masato Nishimura, Ayuka Mineda, Takako Kawakita, Akiko Abe, Minoru Irahara
Exp Ther Med. 2017 Nov; 14(5): 4293–4299. Published online 2017 Aug 28. doi: 10.3892/etm.2017.5061
PMCID:
PMC5647549
AbstractArticlePDF–1.4M
2.
Isolated port site recurrence of node-negative clinical stage IB1 cervical adenocarcinoma
Uma Deshmukh, Molly McAdow, Jonathan Black, Pei Hui, Masoud Azodi
Gynecol Oncol Rep. 2017 May; 20: 54–57. Published online 2017 Mar 6. doi: 10.1016/j.gore.2017.03.001
PMCID:
PMC5348602
AbstractArticlePDF–1.0M
3.
Clear cell adenocarcinoma of cervix in 1-year-old girl without in utero exposure to diethylstilbestrol: an uncommon tumour at an uncommon age and site
Aditi Arora, Anurag Rastogi, Azfar Neyaz, Nuzhat Husain
BMJ Case Rep. 2017; 2017: bcr2016218730. Published online 2017 Mar 16. doi: 10.1136/bcr-2016-218730
PMCID:
PMC5372196
AbstractArticlePDF–998K
4.
Minimal deviation adenocarcinoma of the uterine cervix: A case report
Dah-Ching Ding, Tang-Yuan Chu, Yung-Hsiang Hsu
Tzu Chi Med J. 2016 Apr-Jun; 28(2): 79–81. Published online 2014 Nov 24. doi: 10.1016/j.tcmj.2014.10.001
PMCID:
PMC5442888
AbstractArticlePDF–988K
5.
The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix
Juan Zhou, Wen-Wen Zhang, San-Gang Wu, Zhen-Yu He, Jia-Yuan Sun, Yan Wang, Qiong-Hua Chen
Cancer Manag Res. 2017; 9: 315–322. Published online 2017 Jul 18. doi: 10.2147/CMAR.S141335
PMCID:
PMC5522663
AbstractArticlePDF–395K
6.
Ovarian preservation in adenocarcinoma of the uterine cervix
Jiansong Zhou, Yuanyuan Chen, Ping Zhang, Hanmei Lou
J Ovarian Res. 2017; 10: 48. Published online 2017 Jul 24. doi: 10.1186/s13048-017-0339-y
PMCID:
PMC5525268
AbstractArticlePDF–402K
7.
Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix
Asako Ueda, Akira Takasawa, Taishi Akimoto, Kumi Takasawa, Tomoyuki Aoyama, Yoshihiko Ino, Masanori Nojima, Yusuke Ono, Masaki Murata, Makoto Osanai, Tadashi Hasegawa, Tsuyoshi Saito, Norimasa Sawada
PLoS One. 2017; 12(8): e0184123. Published online 2017 Aug 31. doi: 10.1371/journal.pone.0184123
PMCID:
PMC5578660
AbstractArticlePDF–10M
8.
Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis
Lea A. Moukarzel, Ana M. Angarita, Christopher VandenBussche, Anne Rositch, Carol B. Thompson, Amanda N. Fader, Kimberly Levinson
J Low Genit Tract Dis. Author manuscript; available in PMC 2017 Sep 11.
Published in final edited form as: J Low Genit Tract Dis. 2017 Apr; 21(2): 91–96. doi: 10.1097/LGT.0000000000000286
PMCID:
PMC5593076
AbstractArticlePDF–176K
9.
Metachronous Cancer of Breast and Adenocarcinoma of Cervix: A Rare Case Report
Nalini Sharma, J Lalnunnem Thiek, Das Rituparna, Jaya Mishra, Ahanthem Santa Singh
J Menopausal Med. 2017 Aug; 23(2): 131–134. Published online 2017 Aug 31. doi: 10.6118/jmm.2017.23.2.131
PMCID:
PMC5606911
AbstractArticlePDF–4.1M
10.
Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study
San-Gang Wu, Jia-Yuan Sun, Zhen-Yu He, Qiong-Hua Chen, Juan Zhou
J Gynecol Oncol. 2017 Nov; 28(6): e81. Published online 2017 Sep 8. doi: 10.3802/jgo.2017.28.e81
PMCID:
PMC5641531
AbstractArticlePDF–873K
11.
Locally advanced adenocarcinoma of the cervix on uterus didelphys: a case report
Abel Cordoba, Alexandre Escande, Pauline Comte, Ingrid Fumagalli, Lucie Bresson, Ndaye Mubiayi, Eric Lartigau
J Contemp Brachytherapy. 2017 Feb; 9(1): 71–76. Published online 2017 Jan 31. doi: 10.5114/jcb.2017.65640
PMCID:
PMC5346605
AbstractArticlePDF–1.1M
12.
Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study
Paul A Cohen, Alison Brand, Peter Sykes, David C H Wrede, Orla McNally, Lois Eva, Archana Rao, Michael Campion, Martin Stockler, Aime Powell, Jim Codde, Max K Bulsara, Lyndal Anderson, Yee Leung, Louise Farrell, Pennie Stoyles
BMJ Open. 2017; 7(8): e017576. Published online 2017 Aug 28. doi: 10.1136/bmjopen-2017-017576
PMCID:
PMC5724204
AbstractArticlePDF–561K
13.
Early Stage Adenocarcinoma of Cervix with Ovarian Micrometastasis
Pratibha Singh, Neha Mathur, Suyasha Vyas, Puneet Pareekh
J Midlife Health. 2017 Oct-Dec; 8(4): 194–195. doi: 10.4103/jmh.JMH_52_17
PMCID:
PMC5753503
AbstractArticlePDF–716K
14.
Gastric type mucinous endocervical adenocarcinoma of the uterine cervix: very rare and interesting case
Chul Min Park, Hyun Min Koh, Soyun Park, Hye Sim Kang, Soon Sup Shim, Sung Yob Kim
Obstet Gynecol Sci. 2018 Jan; 61(1): 165–169. Published online 2017 Dec 28. doi: 10.5468/ogs.2018.61.1.165
PMCID:
PMC5780314
AbstractArticlePDF–331K
15.
Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001)
Noriyuki Okonogi, Masaru Wakatsuki, Shingo Kato, Kumiko Karasawa, Hiroki Kiyohara, Shintaro Shiba, Daijiro Kobayashi, Takashi Nakano, Tadashi Kamada, Makio Shozu, the Working Group of Gynecological Tumors
Cancer Med. 2018 Feb; 7(2): 351–359. Published online 2018 Jan 17. doi: 10.1002/cam4.1305
PMCID:
PMC5806111
AbstractArticlePDF–163K
16.
Tumor‐associated CD204+ M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma
Asuka Kawachi, Hiroshi Yoshida, Shigehisa Kitano, Yoshinori Ino, Tomoyasu Kato, Nobuyoshi Hiraoka
Cancer Sci. 2018 Mar; 109(3): 863–870. Published online 2018 Feb 2. doi: 10.1111/cas.13476
PMCID:
PMC5834786
AbstractArticlePDF–1.8M
17.
miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway
Fang Fang, Bangxing Huang, Si Sun, Man Xiao, Jing Guo, Xiaoqing Yi, Jing Cai, Zehua Wang
Cell Death Dis. 2018 Mar; 9(3): 395. Published online 2018 Mar 12. doi: 10.1038/s41419-018-0431-2
PMCID:
PMC5847584
AbstractArticlePDF–4.3M
18.
Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
Megan A. Smith, Karen Canfell
Papillomavirus Res. 2017 Jun; 3: 134–141. Published online 2017 Apr 19. doi: 10.1016/j.pvr.2017.04.003
PMCID:
PMC5883242
AbstractArticlePDF–688K
19.
Prognostic Value of p53 Protein Accumulation in Cancer Cell Nuclei in Adenocarcinoma of the Uterine Cervix
Hitoshi Tsuda, Kumiko Jiko, Shoichiro Tsugane, Masazumi Yajima, Takuro Yamada, Kenjiro Tanemura, Ryuichiro Tsunematsu, Kazuo Ohmi, Takahiko Sonoda, Setsuo Hirohashi
Jpn J Cancer Res. 1995 Nov; 86(11): 1049–1053. doi: 10.1111/j.1349-7006.1995.tb03019.x
PMCID:
PMC5920623
SummaryPDF–288K
20.
Concomitant endometrial and cervical adenocarcinoma: A case report and literature review
Mengfei Xu, Feng Zhou, Lili Huang
Medicine (Baltimore) 2018 Jan; 97(1): e9596. Published online 2018 Jan 5. doi: 10.1097/MD.0000000000009596
PMCID:
PMC5943103
AbstractArticlePDF–7.4M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center